Stem Cell Treatment can Lead to Some Improvement in Babies With Down Syndrome

A three-year-old baby, born with Down Syndrome, had complaints of delayed milestones, lack of voice, cardiac defects, slanted eyes and no neck holding capacity.

Down Syndrome - a genetic disorder - is incurable. However, stem cell experts have reached a conclusion that stem cell treatment can lead to some improvement giving better life even if no permanent cure can be promised.

A three-year-old baby - born with Down Syndrome having subnormal motor skills - has shown improvement after undergoing stem cell treatment at a hospital in New Delhi, doctors said.

Down Syndrome - Trisomy 21, Causes, Symptoms, Diagnosis, Treatment, Prognosis
Down Syndrome is a congenital disorder among children commonly born to older mothers. The condition is also known as ‘Up syndrome’ because of the cheerful persona of the Down children.

‘A three-year-old baby - born with Down Syndrome having subnormal motor skills - has shown improvement after undergoing stem cell treatment.’

Rahul (name changed) was born preterm due to premature rupture of membranes (PROM) and was kept in intensive care unit (ICU) for two days due to respiratory distress.

Following diagnosis of Down Syndrome and subnormal motor skills, the patient was shown to a city-based stem cell expert.

The baby was admitted with complaints of delayed milestones, lack of voice, cardiac defects, slanted eyes and with no neck holding capacity.

New Test To Diagnose Speech and Motor Defects in Down Syndrome
Inability to perform particular purposive actions and unclear articulation of speech are misdiagnosed in children with Down Syndrome.

According to the doctor, the patient underwent two sessions of stem cell therapy of which the first session lasted approximately three months.

"By the end of three months, the muscle tone was better in all limbs. He (patient) had started babbling and crawling. He was social and was able to recognize his near ones after the first session. Better outcomes were observed with no adverse events," said Geeta Shroff, stem cell expert with city-based Nutech Mediworld.

Advertisements

Statistics of Down Syndrome Population in the US may be Overestimated
The new detailed estimation of Down syndrome may be useful for policymakers to better appraise the impact of proposed legislation for this population.

According to Shroff, the results and improvements have shown that the new medical technology has the potential to replace damaged neurons, re-establish lost axonal connections, and provide treatment for various neural and congenital disorders.

"Embryonic stem cell lines used during the treatment have been derived from a single spare fertilized egg that donated during a IVF cycle. This fertilized egg would have otherwise been medical waste," Shroff said.